MLPH — Molecular Pharmacology (USA) Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for Molecular Pharmacology (USA), fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2010 June 30th	2011 June 30th	2012 June 30th	2013 June 30th	2014 June 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.008	0.009	0.003	0.007	0.002
Net Total Accounts Receivable
Net Total Receivables	0.001	0.007	0.005	0.005	0.006
Total Current Assets	0.009	0.015	0.008	0.012	0.009
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.002	0.001	0	0
Total Assets	0.012	0.017	0.009	0.012	0.009
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	1.5	1.98	2.09	2.07	2.24
Total Long Term Debt
Total Debt
Total Liabilities	1.5	1.98	2.09	2.07	2.24
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.49	-1.97	-2.08	-2.05	-2.23
Total Liabilities & Shareholders' Equity	0.012	0.017	0.009	0.012	0.009
Total Common Shares Outstanding